Cardio-Oncology

Articles

Recent
Most accessed

Content type: Research
| 3 September 2018

Tissue Doppler Imaging for anthracycline cardiotoxicity monitoring in pediatric patients with cancer

Authors: Francesco Venturelli, Riccardo Masetti, Marianna Fabi, Roberto Rondelli, Anna Martoni, Arcangelo Prete, Marco Bonvicini and Andrea Pession
Content type: Research
| 29 August 2018

Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers

Authors: Andrew Poklepovic, Yuesheng Qu, Molly Dickinson, Michael C. Kontos, Maciej Kmieciak, Elizabeth Schultz, Dipankar Bandopadhyay, Xiaoyan Deng and Rakesh C. Kukreja
Content type: Review
| 15 June 2018

Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?

Authors: Syril D. Pettit and Rebecca Kirch
Content type: Research
| 1 May 2018

Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines

Authors: Olga H. Toro-Salazar, Ji Hyun Lee, Kia N. Zellars, Paige E. Perreault, Kathryn C. Mason, Zhu Wang, Kan N. Hor, Eileen Gillan, Caroline J. Zeiss, Daniel M. Gatti, Brooke T. Davey, Shelby Kutty, Bruce T. Liang and Francis G. Spinale
Content type: Research
| 20 March 2018

Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

Authors: Raquel Araujo-Gutierrez, Sergio H. Ibarra-Cortez, Jerry D. Estep, Arvind Bhimaraj, Ashrith Guha, Imad Hussain, Myung H. Park, Guillermo Torre-Amione and Barry H. Trachtenberg

Most recent articles RSS

View all articles

Content type: Review
| 9 March 2017

Management of atrial fibrillation in patients taking targeted cancer therapies

Authors: Aarti Asnani, Anastasia Manning, Moussa Mansour, Jeremy Ruskin, Ephraim P. Hochberg and Leon M. Ptaszek
Content type: Review
| 19 April 2016

Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic

Authors: Sergio Barros-Gomes, Joerg Herrmann, Sharon L. Mulvagh, Amir Lerman, Grace Lin and Hector R. Villarraga
Content type: Review
| 4 December 2015

Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia

Authors: Oren Pasvolsky, Avi Leader, Zaza Iakobishvili, Yishay Wasserstrum, Ran Kornowski and Pia Raanani
Content type: Review
| 3 March 2016

Doxorubicin cardiotoxicity and target cells: a broader perspective

Authors: Antonella De Angelis, Konrad Urbanek, Donato Cappetta, Elena Piegari, Loreta Pia Ciuffreda, Alessia Rivellino, Rosa Russo, Grazia Esposito, Francesco Rossi and Liberato Berrino
Content type: Review
| 25 February 2016

Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures

Authors: Anthony F. Yu and Lee W. Jones

Most accessed articles RSS

View all articles

THRIVE grant awards

As a member of the THRIVE advisory board, Cardio-Oncology Editor-in-Chief Steven Lipshultz would like to bring your attention to the THRIVE grant awards. On September 21, 2018, HESI announced the launch of the 2019 THRIVE grant awards as a partner in the inaugural Biden Cancer Summit. A total of $225,000 will be awarded as 4–6 grants available to academic or clinical researchers. Detailed instructions, eligibility, and focus are described on the THRIVE website. Letters of Intent are due October 19, 2018. For more information, contact research@hesithrive.org.

Aims and scope

The editorial mission of Cardio-Oncology is to advance the science and practice of this emerging field to find a balance between oncologic efficacy and reducing adverse cardiovascular effects through timely publication and dissemination of peer-reviewed research. As an open access, online journal Cardio-Oncology provides a high visibility platform for the publication of original research and expert reviews on the cardiovascular effects of cancer treatment.

The journal welcomes submissions to the following sections:

• Adult Oncology - Giuseppe Curigliano and Susan Dent
• Clinical Cardiology - Daniela Cardinale and Daniel Lenihan
• Clinical Trials - Michael S Ewer and Thomas Suter
• Geriatric Oncology - Dawn L Hershman
• Imaging - Steven Colan
• Nursing - Anecita Fadol and Mary McCabe
• Pediatric Oncology - Gregory Armstrong and Stephen E Sallan
• Radiation Oncology - Louis Constine
• Translational Cardiology - Bonnie Ky and Ed TH Yeh

About the society

New Content Item
Cardio-Oncology is the official journal of the International Cardio-Oncology Society (ICOS). The society brings together cardio-oncologists from around the world with the aim of reducing cardiovascular disease in cancer patients and thereby saving patients' lives. For more information about this important work, please visit the ICOS website.

To learn more about the affiliation between Cardio-Oncology and ICOS, please see this blog on the BMC blog network.

About the Editors

Steven Lipshultz, Editor-in-Chief

Steven Lipshultz is the Schotanus Family Professor and Chair of the Carman and Ann Adams Department of Pediatrics at the Wayne State University School of Medicine, as well as the Pediatrician-in-Chief at the Children’s Hospital of Michigan, the Pediatrics Specialist-in-Chief at the Detroit Medical Center, the President of University Pediatricians, and the Interim Director of the Children’s Research Center of Michigan. His primary research interests are in the pediatric cardiomyopathies, especially those of genetic/metabolic, toxic, or infections/inflammatory etiologies.

Joseph Carver, Deputy Editor

Joseph Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center.

Giorgio Minotti, Deputy Editor

Giorgio Minotti is Professor of Pharmacology, Head of Drug Sciences and Clinical Pharmacology, Chief of Clinical Trial Center, at the University Campus Bio-Medico of Rome. His research interests focus on pharmacokinetics, pharmacodynamics, and clinical correlates of anticancer drugs cardiovascular toxicity.

Cardio-Oncology

Articles

Tissue Doppler Imaging for anthracycline cardiotoxicity monitoring in pediatric patients with cancer

Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers

Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?

Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines

Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

Management of atrial fibrillation in patients taking targeted cancer therapies

Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic

Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia

Doxorubicin cardiotoxicity and target cells: a broader perspective

Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures

THRIVE grant awards

Aims and scope

About the society

About the Editors

Affiliated with

2017 Journal Metrics

Cardio-Oncology

Contact us